Syndax Pharmaceuticals, Inc. (SNDX)
19.77
-0.36
(-1.79%)
USD |
NASDAQ |
May 21, 16:00
20.09
+0.32
(+1.62%)
After-Hours: 04:03
Syndax Pharmaceuticals Research and Development Expense (TTM) : 255.98M for March 31, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Cogent Biosciences, Inc. | 277.48M |
| Vera Therapeutics, Inc. | 259.47M |
| Biogen, Inc. | 1.607B |
| Amgen, Inc. | 7.514B |
| Ardelyx, Inc. | 73.40M |